X0306 4/A 2017-02-01 2017-02-03 0 0001578845 Allergan plc AGN 0001237253 BISARO PAUL CLONSHAUGH BUSINESS AND TECHNOLOGY PARK, COOLOCK, CO. DUBLIN L2 D17 E400 IRELAND 1 0 0 0 Ordinary Shares, par value $0.0001 2017-02-01 4 A 0 7105 229.32 A 308867 D Ordinary Shares, par value $0.0001 2017-02-01 4 F 0 3411 229.32 D 305456 D Ordinary Shares, par value $0.0001 120000 I Paul Bisaro LLC Ordinary Shares, par value $0.0001 229.32 2017-02-01 4 C 0 7105 0 A 2017-02-01 2017-02-01 Ordinary Shares 7105 0 D Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc. Represents performance-based restricted share units ("PSUs") which vested on February 1, 2017, following certification of achievement by issuer of certain performance criteria. Each PSU represented a contingent right to receive ordinary shares of the Issuer equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and Reporting Person. This amendment to the Form 4 filed on February 3, 2017 is being filed in order to: (1) correct an administrative error whereby 120,000 ordinary shares, par value $0.0001 (the "Ordinary Shares"), were inadvertently excluded in the Reporting Person's direct ownership value and (2) properly reflect 120,000 shares held in Paul Bisaro LLC ("LLC"), an LLC in which Mr. Bisaro retains an ownership interest and might be deemed to have or share investment control. /s/ A. Robert D. Bailey, Attorney-in-Fact for the Reporting Person 2017-02-06